mianserin has been researched along with Psychotic Disorders in 20 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy of mirtazapine as an adjunctive treatment of negative symptoms in patients with chronic schizophrenia via meta-analysis." | 8.91 | Meta-Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in Schizophrenia. ( Chiapelli, J; Fischer, BA; Himelhoch, S; Reese, C; Vidal, C, 2015) |
| "To our knowledge, this is the second reported case of Status epilepticus that has been associated with the use of olanzapine, while only one report of seizures, but none of Status epilepticus connected to mirtazapine is found in the literature." | 7.75 | Status epilepticus in a patient treated with olanzapine and mirtazapine. ( Iacovides, A; Kaprinis, G; Nimatoudis, J; Sokolaki, S; Spyridi, S, 2009) |
| "Mirtazapine is an antidepressant with a mechanism that involves activating serotonin (5-HT1) receptors." | 6.47 | Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. ( Huang, KC; Lee, WK; Li, TC; Shiah, IS; Sun, CJ; Tzang, RF, 2011) |
| "To assess the efficacy of mirtazapine as an adjunctive treatment of negative symptoms in patients with chronic schizophrenia via meta-analysis." | 4.91 | Meta-Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in Schizophrenia. ( Chiapelli, J; Fischer, BA; Himelhoch, S; Reese, C; Vidal, C, 2015) |
| "A 40-year old woman with a history of acute psychotic symptoms developed agranulocytosis and neutropenia after starting therapy that included lamotrigine, mirtazapine, quetiapine, and venlafaxine." | 3.78 | Fatal agranulocytosis associated with psychotropic medication use. ( Al-Najjar, T; Ali, BA; Nazer, LH; Shankar, G, 2012) |
| "To our knowledge, this is the second reported case of Status epilepticus that has been associated with the use of olanzapine, while only one report of seizures, but none of Status epilepticus connected to mirtazapine is found in the literature." | 3.75 | Status epilepticus in a patient treated with olanzapine and mirtazapine. ( Iacovides, A; Kaprinis, G; Nimatoudis, J; Sokolaki, S; Spyridi, S, 2009) |
| " Adding risperidone to mirtazapine probably does not necessitate a change of the dosage of either drug, but more extensive investigations are needed." | 2.69 | Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study. ( Doorschot, CH; Loonen, AJ; Oostelbos, MC; Sitsen, JM, 1999) |
| "Mirtazapine is an antidepressant with a mechanism that involves activating serotonin (5-HT1) receptors." | 2.47 | Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. ( Huang, KC; Lee, WK; Li, TC; Shiah, IS; Sun, CJ; Tzang, RF, 2011) |
| "However, diagnosis of schizoaffective disorder is included both in DSM-IV-TR and ICD-10." | 2.41 | [Schizoaffective disorder: clinical symptoms and present-day approach to treatment]. ( Danileviciūte, V, 2002) |
| "Mirtazapine is a presynaptic alpha-2 antagonist that has dual action by increasing noradrenergic and serotonergic neurotransmission." | 2.40 | Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. ( Barkin, RL; Fawcett, J, 1998) |
| "Haloperidol was discontinued, but mirtazapine was continued, and the vivid dream activity persisted; however, reality testing when awake was intact." | 1.36 | Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment. ( Felthous, AR; Hoevet, R; Wenger, PJ, 2010) |
| "Priapism is a "persistent erection not accompanied by sexual desire or stimulation, usually lasting more than six hours and typically involving only the corpora cavernosa." | 1.33 | Priapism and quetiapine: a case report. ( Dilley, JW; Harrison, G; Loeb, L; Nelson, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamadjida, A | 1 |
| Nuara, SG | 1 |
| Gourdon, JC | 1 |
| Huot, P | 1 |
| Vidal, C | 1 |
| Reese, C | 1 |
| Fischer, BA | 1 |
| Chiapelli, J | 1 |
| Himelhoch, S | 1 |
| Tagai, K | 1 |
| Nagata, T | 1 |
| Shinagawa, S | 1 |
| Tsuno, N | 1 |
| Ozone, M | 1 |
| Nakayama, K | 1 |
| Godschalx-Dekker, JA | 1 |
| Siegers, HP | 1 |
| Spyridi, S | 1 |
| Sokolaki, S | 1 |
| Nimatoudis, J | 1 |
| Iacovides, A | 1 |
| Kaprinis, G | 1 |
| Felthous, AR | 1 |
| Wenger, PJ | 1 |
| Hoevet, R | 1 |
| Li, TC | 1 |
| Shiah, IS | 1 |
| Sun, CJ | 1 |
| Tzang, RF | 1 |
| Huang, KC | 1 |
| Lee, WK | 1 |
| Nazer, LH | 1 |
| Shankar, G | 1 |
| Ali, BA | 1 |
| Al-Najjar, T | 1 |
| Danileviciūte, V | 1 |
| Klein, JP | 1 |
| Fiedler, U | 1 |
| Appel, H | 1 |
| Quante, A | 1 |
| Jockers-Scherübl, MC | 1 |
| Harrison, G | 1 |
| Dilley, JW | 1 |
| Loeb, L | 1 |
| Nelson, K | 1 |
| Mutschler, J | 1 |
| Czell, D | 1 |
| Kaps, M | 1 |
| Manzl, G | 1 |
| Fawcett, J | 1 |
| Barkin, RL | 1 |
| Birkenhäger, TK | 1 |
| Moleman, P | 2 |
| Loonen, AJ | 1 |
| Doorschot, CH | 1 |
| Oostelbos, MC | 1 |
| Sitsen, JM | 1 |
| Moustgaard, G | 1 |
| Poyurovsky, M | 1 |
| Weizman, A | 1 |
| Bruijn, JA | 1 |
| Mulder, PG | 1 |
| van den Broek, WW | 1 |
| Perry, GF | 1 |
| Fitzsimmons, B | 1 |
| Shapiro, L | 1 |
| Irwin, P | 1 |
| Koponen, H | 1 |
| Honkonen, S | 1 |
| Partanen, J | 1 |
| Riekkinen, PJ | 1 |
5 reviews available for mianserin and Psychotic Disorders
| Article | Year |
|---|---|
Meta-Analysis of Efficacy of Mirtazapine as an Adjunctive Treatment of Negative Symptoms in Schizophrenia.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Drug Therapy, Combination; Humans; Mianserin | 2015 |
Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Electroconvulsive Therapy; Fema | 2011 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic | 2002 |
Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
Topics: Administration, Oral; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Clinical T | 1998 |
[Two new antidepressants: mirtazapine and venlafaxine].
Topics: Adrenergic alpha-Antagonists; Benzamides; Cyclohexanols; Depressive Disorder; Drug Interactions; Fem | 1999 |
2 trials available for mianserin and Psychotic Disorders
| Article | Year |
|---|---|
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Depressive Disorder | 1999 |
Clinical study of mianserin, imipramine and placebo in depression: blood level and MHPG correlations.
Topics: Adjustment Disorders; Adolescent; Adult; Affective Disorders, Psychotic; Aged; Clinical Trials as To | 1978 |
13 other studies available for mianserin and Psychotic Disorders
| Article | Year |
|---|---|
The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset.
Topics: Animals; Antidepressive Agents, Second-Generation; Callithrix; Disease Models, Animal; Dose-Response | 2018 |
Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
Topics: Aged, 80 and over; Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Female; Halluc | 2013 |
Reduction of parkinsonism and psychosis with mirtazapine: a case report.
Topics: Aged; Histamine H1 Antagonists; Humans; Male; Mianserin; Mirtazapine; Parkinsonian Disorders; Psycho | 2014 |
Status epilepticus in a patient treated with olanzapine and mirtazapine.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Drug Interactions; Female; | 2009 |
Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Depressive Disorder, Major; Dreams; Ha | 2010 |
Fatal agranulocytosis associated with psychotropic medication use.
Topics: Adult; Agranulocytosis; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Ag | 2012 |
Massive creatine kinase elevations with quetiapine: report of two cases.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Creatine Kinase; Depressive Disorder, | 2006 |
Priapism and quetiapine: a case report.
Topics: Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Comorbidity; Depressive Disorder; | 2006 |
[Psychotic symptoms in a case of locked-in syndrome].
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Brain Stem; Cerebral Hemorrhage; Delusions; | 2006 |
Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
Topics: Antidepressive Agents, Tricyclic; Antimanic Agents; Depressive Disorder, Major; Drug Therapy, Combin | 2000 |
Mirtazapine for neuroleptic-induced akathisia.
Topics: Adrenergic alpha-Antagonists; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Haloperidol; Hum | 2001 |
Treatment of mood-congruent psychotic depression with imipramine.
Topics: Adolescent; Adult; Affect; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Im | 2001 |
[Symptoms of Creutzfeldt-Jakob disease during mianserin therapy].
Topics: Aged; Creutzfeldt-Jakob Syndrome; Depression; Epilepsy; Epilepsy, Tonic-Clonic; Female; Humans; Male | 1991 |